Detailed Information for N00100
IPAD-DB ID N00100
Name ALNs with curcumin
Category Nano-inhibitors
EC50
IC50
Inhibition
Toxicity
ROS(reactive oxygen species)
Metal Chelating
BBB(blood-brain barrier)
Target Protein Aβ
Effects The new amylolipid hybrid type of the nano-formulation presented in this paper, enhanced the brain bioavailability of CUR via the nose-to brain route as compared to IV administration.
Research Models
Main Source
Ref. Link